April 9, 2024

National Journal Devotes Issue to Project Led by TRI’s Laura James, M.D.

David Robinson

UAMS Translational Research Institute Director Laura James, M.D., led a team of five guest editors from institutions across the United States who were published on their efforts to improve clinical trials.

UAMS Translational Research Institute (TRI) Director Laura James, M.D., concluded her tenure as co-chair of the national Clinical and Translational Sciences Award (CTSA) Steering Committee in December with an effort aimed at making clinical trials more informative and of higher quality. Her work, and those of other CTSA leaders, appears in a themed issue of…


April 4, 2024

NIH Awards UAMS Researchers $2.27 Million to Study Estrogen’s Role in Preventing Bone Loss

David Robinson

UAMS’ Maria Schuller Almeida, Ph.D. (left), and Ha-Neui (Hans) Kim, Ph.D., will use new funding from the National Institutes of Health to answer key questions about estrogen’s important role in preventing bone loss.

LITTLE ROCK — Researchers at the University of Arkansas for Medical Sciences (UAMS) will use a $2.27 million grant from the National Institutes of Health (NIH) to answer key questions about the cellular mechanisms used by estrogen to prevent bone loss and osteoporosis. The five-year NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases…


April 3, 2024

Three UAMS Research Teams Named Inaugural Recipients of BioVentures Accelerator Awards

David Robinson

UAMS’ Gyan Sahukhal, Ph.D., Samir Jenkins, Ph.D., and Mitchell McGill, Ph.D., are the first researchers to receive financial and other support from the new AR Health Ventures Accelerator (ARHVA) program.

BioVentures LLC at UAMS recently announced the selection of three UAMS research teams as the inaugural recipients of its new AR Health Ventures Accelerator (ARHVA) program. The accelerator program, which aims to help jump-start the translation of promising scientific discoveries into therapies, is providing the selected projects with substantial benefits, including financial grants up to…


February 9, 2024

NIH Funds Study of UAMS Nurses’ Influence on Heart Failure Patient Outcomes

David Robinson

Tremaine Williams, Ed.D., at his desk at UAMS.

A University of Arkansas for Medical Sciences (UAMS) research team led by Tremaine Williams, Ed.D., has received a National Institutes of Health (NIH) grant to better understand how nurses influence outcomes of heart failure patients. About 6.2 million people in the United States have heart failure. The two-year, $406,897 R21 grant from the NIH National…


February 6, 2024

UAMS Research Team Discovers Potential Alzheimer’s Drug

David Robinson

UAMS' Sue Griffin, Ph.D., and Meenakshisundaram, Balasubramaniam, Ph.D., led the discovery of the potential Alzheimer's drug for people with the inherited Alzheimer's gene.

LITTLE ROCK — A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D. The findings were published Jan. 8 in Communications Biology and include discoveries of a druggable target and a…


January 30, 2024

Teenage Researcher Leads UAMS Parkinson’s Study Published in Scientific Reports

David Robinson

Anu Iyer began working on the machine learning Parkinson's disease study at UAMS as a high school student.

LITTLE ROCK — Eighteen-year-old Anu Iyer, the recent Little Rock Central High School graduate and machine-learning sensation collaborating with a University of Arkansas for Medical Sciences (UAMS) research team, is the lead author on a publication in Scientific Reports, part of the Nature portfolio journals. She was joined as co-first author by UAMS’ Aaron Kemp,…


December 18, 2023

UAMS Translational Research Institute Honors Community Partners

David Robinson

Joyce Raynor, center, executive director of the Center for Healing Hearts & Spirits, receives the Chancellor's Community Engaged Research Partner of the Year Award. She is joined by TRI's (l-r) Tiffany Haynes, Ph.D., and Christi Madden, MPA, and Darlynton Adegor of Healing Hearts & Spirits.

For Joyce Raynor, winning the Chancellor’s Community Engaged Research Partner of the Year Award affirmed many years of hard work. “This award means that we’re on the right track,” said Raynor, founder and executive director of the Center for Healing Hearts & Spirits, which helps victims of violence. “It means that our partnership with UAMS…


December 15, 2023

UAMS Myeloma Researcher Sees‘ Impressive’ Results in Clinical Trials of Bispecific Antibody Treatments

David Robinson

Carolina Schinke, M.D.

Many patients at the UAMS Myeloma Center have relapsed refractory myeloma, meaning they have nearly run out of effective treatment options. Fortunately, the center has talented clinical researchers like Carolina Schinke, M.D., with access to the latest medications, including promising study drugs. Schinke is leading a clinical trial at UAMS of a promising new bispecific…


December 14, 2023

UAMS Researcher Takes Aim at Drug-Resistant Myeloma

David Robinson

Fenghuang (Frank) Zhan, M.D., Ph.D.

  UAMS Myeloma Center researcher Fenghuang (Frank) Zhan, M.D., Ph.D., has spent his career in search of clues to help fight drug-resistant myeloma. His findings recently led him to establish a translational research project to beat drug-resistant myeloma for his 11-member myeloma research team, based at the UAMS Winthrop P. Rockefeller Cancer Institute. While the…


December 5, 2023

UAMS Researcher Receives $1.8 Million NIH Grant to Study Key Cell Processes in Energy Production

David Robinson

Huiliang Zhang, Ph.D., in his lab at UAMS.

LITTLE ROCK — Huiliang Zhang, Ph.D., at the University of Arkansas for Medical Sciences (UAMS), will use a $1.8 million grant from the National Institutes of Health (NIH) to study proton leak, a process within the body that affects metabolism and energy. Although scientists have been aware of proton leak for decades, Zhang said, little…



Next page